NYMX
Nymox Pharmaceutical Corp
NYMX
NYMX
Delisted
NYMX was delisted on the 6th of July, 2023.
34 hedge funds and large institutions have $495K invested in Nymox Pharmaceutical Corp in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
45% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 11
Holders
34
Holding in Top 10
–
Calls
$7K
Puts
$9K
Top Buyers
| 1 | +$15.1K | |
| 2 | +$12K | |
| 3 | +$11.1K | |
| 4 |
GG
Gofen & Glossberg
Chicago,
Illinois
|
+$9.94K |
| 5 |
CAN
Cetera Advisor Networks
El Segundo,
California
|
+$6.81K |
Top Sellers
| 1 | -$37K | |
| 2 | -$35K | |
| 3 | -$22K | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$13K |
| 5 |
BAS
Brown Advisory Securities
Baltimore,
Maryland
|
-$12K |